Effects of experimental diabetes on C/EBP proteins in rat hippocampus, sciatic nerve and ganglia

Cellular and Molecular Neurobiology

Volumn 33, Issue 4, 2013, Pages 559-567

  Kazkayasi, Inci ^a   Burul Bozkurt, Nihan ^a   Önder, Sevgen ^a   Kelicen Ugur, Pelin ^a   Pekiner, Can ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

C EBP; Diabetes mellitus; Ganglion; Hippocampus; Neurodegeneration; Sciatic nerve

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; CCAAT ENHANCER BINDING PROTEIN ALPHA; CCAAT ENHANCER BINDING PROTEIN BETA; GLUCOSE; INSULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIABETES MELLITUS; DRUG IMPLANT; EXPERIMENTAL DIABETES MELLITUS; GANGLION; GLUCOSE BLOOD LEVEL; HIPPOCAMPUS; IMMUNOREACTIVITY; INSULIN TREATMENT; MALE; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; RAT; SCIATIC NERVE; STREPTOZOCIN DIABETES; WESTERN BLOTTING;

ANIMALS; BLOOD GLUCOSE; BLOTTING, WESTERN; BODY WEIGHT; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CCAAT-ENHANCER-BINDING PROTEIN-BETA; DIABETES MELLITUS, EXPERIMENTAL; GANGLIA; HIPPOCAMPUS; INSULIN; MALE; RATS; RATS, SPRAGUE-DAWLEY; SCIATIC NERVE;

RATTUS;

EID: 84876673687     PISSN: 02724340     EISSN: 15736830     Source Type: Journal    
DOI: 10.1007/s10571-013-9924-9     Document Type: Article

References (57)

1. Alam T, An MR, Papaconstantinou J (1992) Differential expression of three C/EBP isoforms in multiple tissues during the acute phase response. J Biol Chem 267(8):5021-5024
2. Alberini CM, Ghirardi M, Metz R, Kandel ER (1994) C/EBP is an immediate-early gene required for the consolidation of long-term facilitation in Aplysia. Cell 76(6):1099-1114
3. Alberti K, Zimmet P, Consultation W (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med 15(7):539-553
4. Amthor KF, Dahl-Jorgensen K, Berg TJ, Heier MS, Sandvik L, Aagenaes O, Hanssen KF (1994) The effect of 8 years of strict glycaemic control on peripheral nerve function in IDDM patients: the Oslo Study. Diabetologia 37(6):579-584
5. Arizmendi C, Liu S, Croniger C, Poli V, Friedman JE (1999) The transcription factor CCAAT/enhancer-binding protein beta regulates gluconeogenesis and phosphoenolpyruvate carboxykinase (GTP) gene transcription during diabetes. J Biol Chem 274(19):13033-13040
6. Bosch F, Sabater J, Valera A (1995) Insulin inhibits liver expression of the CCAAT/enhancer-binding protein beta. Diabetes 44(3):267-271
7. Bravenboer B, Kappelle AC, van Buren T, Erkelens DW, Gispen WH (1993) ACTH4-9 analogue ORG 2766 can improve existing neuropathy in streptozocin-induced diabetic rats. Acta Diabetol 30(1):21-24
8. Burul-Bozkurt N, Pekiner C, Kelicen P (2010a) Diabetes alters aromatase enzyme levels in gonadal tissues of rats. Naunyn Schmiedebergs Arch Pharmacol 382(1):33-41
9. Burul-Bozkurt N, Pekiner C, Kelicen P (2010b) Diabetes alters aromatase enzyme levels in sciatic nerve and hippocampus tissues of rats. Cell Mol Neurobiol 30(3):445-451
10. Calella AM, Nerlov C, Lopez RG, Sciarretta C, von Bohlen und Halbach O, Bereshchenko O, Minichiello L (2007) Neurotrophin/Trk receptor signaling mediates C/EBPalpha, -beta and NeuroD recruitment to immediate-early gene promoters in neuronal cells and requires C/EBPs to induce immediate-early gene transcription. Neural Dev 2:4
11. Cameron NE, Cotter MA, Maxfield EK (1993) Anti-oxidant treatment prevents the development of peripheral nerve dysfunction in streptozotocin-diabetic rats. Diabetologia 36(4):299-304
12. Cao Z, Umek RM, McKnight SL (1991) Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev 5(9):1538-1552
13. Cardinaux JR, Allaman I, Magistretti PJ (2000) Pro-inflammatory cytokines induce the transcription factors C/EBPbeta and C/EBPdelta in astrocytes. Glia 29(1):91-97
14. Cermenati G, Abbiati F, Cermenati S, Brioschi E, Volonterio A, Cavaletti G, Saez E, De Fabiani E, Crestani M, Garcia-Segura LM, Melcangi RC, Caruso D, Mitro N (2012) Diabetes-induced myelin abnormalities are associated with an altered lipid pattern: protective effects of LXR activation. J Lipid Res 53(2):300-310
15. Christy RJ, Kaestner KH, Geiman DE, Lane MD (1991) CCAAT/enhancer binding protein gene promoter: binding of nuclear factors during differentiation of 3T3-L1 preadipocytes. Proc Natl Acad Sci U S A 88(6):2593-2597
16. Cortes-Canteli M, Wagner M, Ansorge W, Perez-Castillo A (2004) Microarray analysis supports a role for CCAAT/enhancer-binding protein-beta in brain injury. J Biol Chem 279(14):14409-14417
17. Cotter MA, Dines KC, Cameron NE (1993) Prevention and reversal of motor and sensory peripheral nerve conduction abnormalities in streptozotocin-diabetic rats by the prostacyclin analogue iloprost. Naunyn Schmiedebergs Arch Pharmacol 347(5):534-540
18. Darlington GJ, Ross SE, MacDougald OA (1998) The role of C/EBP genes in adipocyte differentiation. J Biol Chem 273(46):30057-30060
19. Gispen WH, Biessels GJ (2000) Cognition and synaptic plasticity in diabetes mellitus. Trends Neurosci 23(11):542-549
20. Hemati N, Ross SE, Erickson RL, Groblewski GE, MacDougald OA (1997) Signaling pathways through which insulin regulates CCAAT/enhancer binding protein alpha (C/EBPalpha) phosphorylation and gene expression in 3T3-L1 adipocytes. Correlation with GLUT4 gene expression. J Biol Chem 272(41):25913-25919
21. Kapadia R, Tureyen K, Bowen KK, Kalluri H, Johnson PF, Vemuganti R (2006) Decreased brain damage and curtailed inflammation in transcription factor CCAAT/enhancer binding protein beta knockout mice following transient focal cerebral ischemia. J Neurochem 98(6):1718-1731
22. 2+ antagonist, nimodipine of an existing neuropathy in the streptozotocin-induced, diabetic rat. Br J Pharmacol 108(3):780-785
23. King GL (2008) The role of inflammatory cytokines in diabetes and its complications. J Periodontol 79(8 Suppl):1527-1534
24. Kuhad A, Sethi R, Chopra K (2008) Lycopene attenuates diabetes-associated cognitive decline in rats. Life Sci 83(3-4):128-134
25. Kuo CF, Xanthopoulos KG, Darnell JE Jr (1990) Fetal and adult localization of C/EBP: evidence for combinatorial action of transcription factors in cell-specific gene expression. Development 109(2):473-481
26. Lekstrom-Himes J, Xanthopoulos KG (1998) Biological role of the CCAAT/enhancer-binding protein family of transcription factors. J Biol Chem 273(44):28545-28548
27. Leonard BE (2007) Inflammation, depression and dementia: are they connected? Neurochem Res 32(10):1749-1756
28. Lin FT, Lane MD (1992) Antisense CCAAT/enhancer-binding protein RNA suppresses coordinate gene expression and triglyceride accumulation during differentiation of 3T3-L1 preadipocytes. Genes Dev 6(4):533-544
29. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193(1):265-275
30. Lu M, Seufert J, Habener JF (1997) Pancreatic beta-cell-specific repression of insulin gene transcription by CCAAT/enhancer-binding protein beta. Inhibitory interactions with basic helix-loop-helix transcription factor E47. J Biol Chem 272(45):28349-28359
31. MacDougald OA, Cornelius P, Liu R, Lane MD (1995) Insulin regulates transcription of the CCAAT/enhancer binding protein (C/EBP) alpha, beta, and delta genes in fully-differentiated 3T3-L1 adipocytes. J Biol Chem 270(2):647-654
32. Marshall J, Dolan BM, Garcia EP, Sathe S, Tang X, Mao Z, Blair LA (2003) Calcium channel and NMDA receptor activities differentially regulate nuclear C/EBPbeta levels to control neuronal survival. Neuron 39(4):625-639
33. Menard C, Hein P, Paquin A, Savelson A, Yang XM, Lederfein D, Barnabe-Heider F, Mir AA, Sterneck E, Peterson AC, Johnson PF, Vinson C, Miller FD (2002) An essential role for a MEK-C/EBP pathway during growth factor-regulated cortical neurogenesis. Neuron 36(4):597-610
34. Nadeau S, Hein P, Fernandes KJ, Peterson AC, Miller FD (2005) A transcriptional role for C/EBP beta in the neuronal response to axonal injury. Mol Cell Neurosci 29(4):525-535
35. Obrosova IG (2009) Diabetes and the peripheral nerve. Biochim Biophys Acta 1792(10):931-940
36. Olofsson LE, Orho-Melander M, William-Olsson L, Sjoholm K, Sjostrom L, Groop L, Carlsson B, Carlsson LM, Olsson B (2008) CCAAT/enhancer binding protein alpha (C/EBPalpha) in adipose tissue regulates genes in lipid and glucose metabolism and a genetic variation in C/EBPalpha is associated with serum levels of triglycerides. J Clin Endocrinol Metab 93(12):4880-4886
37. Otto TC, Lane MD (2005) Adipose development: from stem cell to adipocyte. Crit Rev Biochem Mol Biol 40(4):229-242
38. Paquin A, Barnabe-Heider F, Kageyama R, Miller FD (2005) CCAAT/enhancer-binding protein phosphorylation biases cortical precursors to generate neurons rather than astrocytes in vivo. J Neurosci 25(46):10747-10758
39. Perez-Capote K, Saura J, Serratosa J, Sola C (2006) Expression of C/EBPalpha and C/EBPbeta in glial cells in vitro after inducing glial activation by different stimuli. Neurosci Lett 410(1):25-30
40. Piotrowski P, Wierzbicka K, Smialek M (2001) Neuronal death in the rat hippocampus in experimental diabetes and cerebral ischaemia treated with antioxidants. Folia Neuropathol 39(3):147-154
41. Poli V (1998) The role of C/EBP isoforms in the control of inflammatory and native immunity functions. J Biol Chem 273(45):29279-29282
42. Ramji DP, Foka P (2002) CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem J 365(Pt 3):561-575
43. Reagan LP (2007) Insulin signaling effects on memory and mood. Curr Opin Pharmacol 7(6):633-637
44. Reisi P, Alaei H, Babri S, Sharifi MR, Mohaddes G (2009) Effects of treadmill running on spatial learning and memory in streptozotocin-induced diabetic rats. Neurosci Lett 455(2):79-83
45. Roriz-Filho SJ, Sa-Roriz TM, Rosset I, Camozzato AL, Santos AC, Chaves ML, Moriguti JC, Roriz-Cruz M (2009) (Pre)diabetes, brain aging, and cognition. Biochim Biophys Acta 1792(5):432-443
46. Ross SE, Erickson RL, Hemati N, MacDougald OA (1999) Glycogen synthase kinase 3 is an insulin-regulated C/EBPalpha kinase. Mol Cell Biol 19(12):8433-8441
47. Said G (2007) Diabetic neuropathy - a review. Nat Clin Pract Neurol 3(6):331-340
48. Soga Y, Yamanaka R, Nishino K, Tanaka R (2003) CCAAT/enhancer binding proteins are expressed in the gerbil hippocampus after transient forebrain ischemia. Neurosci Lett 337(2):106-110
49. Sterneck E, Johnson PF (1998) CCAAT/enhancer binding protein beta is a neuronal transcriptional regulator activated by nerve growth factor receptor signaling. J Neurochem 70(6):2424-2433
50. Stranahan AM, Arumugam TV, Cutler RG, Lee K, Egan JM, Mattson MP (2008) Diabetes impairs hippocampal function through glucocorticoid-mediated effects on new and mature neurons. Nat Neurosci 11(3):309-317
51. Taubenfeld SM, Wiig KA, Monti B, Dolan B, Pollonini G, Alberini CM (2001) Fornix-dependent induction of hippocampal CCAAT enhancer-binding protein [beta] and [delta] Co-localizes with phosphorylated cAMP response element-binding protein and accompanies long-term memory consolidation. J Neurosci 21(1):84-91
52. ter Laak M, Lankhorst A, Schrama L, Gispen W (2000) Neuropathies. Neuroscience Research Communications 26(3):227-239
53. Tesfaye S, Stevens LK, Stephenson JM, Fuller JH, Plater M, Ionescu-Tirgoviste C, Nuber A, Pozza G, Ward JD (1996) Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study. Diabetologia 39(11):1377-1384
54. Verheijen MH, Chrast R, Burrola P, Lemke G (2003) Local regulation of fat metabolism in peripheral nerves. Genes Dev 17(19):2450-2464
55. Webster NJ, Kong Y, Cameron KE, Resnik JL (1994) An upstream element from the human insulin receptor gene promoter contains binding sites for C/EBP beta and NF-1. Diabetes 43(2):305-312
56. 2+/calmodulin kinases activation in hippocampal neurons. J Biol Chem 273(47):31345-31351
57. Zador IZ, Hsieh CC, Papaconstantinou J (1998) Renal CCAAT/enhancer- binding proteins in experimental diabetes mellitus. Nephron 79(3):312-316